Selection and Validation of Induction Chemotherapy Beneficiaries Among Patients With T3N0, T3N1, T4N0 Nasopharyngeal Carcinoma Using Epstein-Barr Virus DNA: A Joint Analysis of Real-World and Clinical Trial Data
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selection and Validation of Induction Chemotherapy Beneficiaries Among Patients With T3N0, T3N1, T4N0 Nasopharyngeal Carcinoma Using Epstein-Barr Virus DNA: A Joint Analysis of Real-World and Clinical Trial Data
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-11-29
DOI
10.3389/fonc.2019.01343
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial
- (2019) Wen-Fei Li et al. INTERNATIONAL JOURNAL OF CANCER
- Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
- (2019) Yuan Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial
- (2019) Qi Yang et al. EUROPEAN JOURNAL OF CANCER
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The addition of pretreatment plasma Epstein-Barr virus DNA into the 8th edition of nasopharyngeal cancer TNM stage classification
- (2018) Victor Ho-Fun Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma
- (2018) Rui Guo et al. CANCER
- Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial
- (2017) Su-Mei Cao et al. EUROPEAN JOURNAL OF CANCER
- Current State of PCR-Based Epstein-Barr Virus DNA Testing for Nasopharyngeal Cancer
- (2017) Kelly Y. Kim et al. JNCI-Journal of the National Cancer Institute
- Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer
- (2017) K.C. Allen Chan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Establishing and applying nomograms based on the 8th edition of the UICC/AJCC staging system to select patients with nasopharyngeal carcinoma who benefit from induction chemotherapy plus concurrent chemoradiotherapy
- (2017) Cheng Xu et al. ORAL ONCOLOGY
- Prognostic value of chemotherapy in addition to concurrent chemoradiotherapy in T3-4N0-1 nasopharyngeal carcinoma: a propensity score matching study
- (2017) Li-Rong Wu et al. Oncotarget
- Current State of PCR-Based Epstein-Barr Virus DNA Testing for Nasopharyngeal Cancer
- (2017) Kelly Y. Kim et al. JNCI-Journal of the National Cancer Institute
- Impact of marital status at diagnosis on survival and its change over time between 1973 and 2012 in patients with nasopharyngeal carcinoma: a propensity score-matched analysis
- (2017) Cheng Xu et al. Cancer Medicine
- Head and Neck Cancers, Version 2.2014
- (2017) David G. Pfister et al. Journal of the National Comprehensive Cancer Network
- Sex Differences in Lifespan
- (2016) Steven N. Austad et al. Cell Metabolism
- Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
- (2016) Ying Sun et al. LANCET ONCOLOGY
- Real-World Evidence — What Is It and What Can It Tell Us?
- (2016) Rachel E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial
- (2011) Lei Chen et al. LANCET ONCOLOGY
- Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal Carcinoma
- (2010) W.-Y. Wang et al. CLINICAL CANCER RESEARCH
- Future of the TNM classification and staging system in head and neck cancer
- (2010) Robert P. Takes et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Randomized Trial of Radiotherapy Plus Concurrent-Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma
- (2010) A. W. M. Lee et al. JNCI-Journal of the National Cancer Institute
- Re-Evaluation of 6th Edition of AJCC Staging System for Nasopharyngeal Carcinoma and Proposed Improvement Based on Magnetic Resonance Imaging
- (2009) Yan-Ping Mao et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started